ProWomanProLife

  • The Story
  • The Women
  • Notable Columns
  • Contact Us
You are here: Home / All Posts / Just to be clear…

Just to be clear…

November 27, 2013 by Natalie Sonnen Leave a Comment

In case the Canadian Medical Association Journal wasn’t clear on the harms of the RU486 drug cocktail they call “the gold standard” for abortions, this will help.  Celeste McGovern, an excellent investigative journalist, had this piece a few years back.  Misopristol is the drug used in combination with mifepristone to make up the RU486 regime.  Misopristol was designed to address gastric ulcers, it was never intended for “pregnancy termination.”

Just weeks before the FDA approved RU- 486, G.D. Searle, the manufacturer of misopristol, issued a “physician alert” to the FDA and to every obstetrician and gynecologist in the USA, warning that misopristol “is not approved for the induction of labor or abortion.”

The Peapack, N.J.-based subsidiary of Pharmacia Inc. said that misopristol, sold under the shelf name Cytotec, was developed and clinically tested only to treat gastric ulcers. Searle warned, “Serious adverse events reported following off-label use of Cytotec in pregnant women include maternal or fetal death, uterine hyperstimulation, rupture or perforation requiring uterine surgical repair, hysterectomy … amniotic fluid embolism, vaginal bleeding, retained placenta, shock, fetal bradycardia and pelvic pain.”

The FDA, which had recommended that misopristol be used in combination with mifepristone as part of RU-486 treatment, posted Searle’s warning letter on its Web site, but did not withdraw its recommendation. The Population Council would not release a copy of the informed-consent papers women in the trial signed before taking part in the Canadian study, and Horzepa refused to say if the women in the trial were aware of the Searle letter.

Roslyn Tremblay, a spokeswoman for Canada’s federal health department, also declined to confirm if the women in the study were aware of the warning. “Within the Canadian context, any research information is proprietary information and would have to be released by the company,” said Tremblay.

But abortionist Wiebe disclosed that none of the women were informed about Searle’s physician alert.

Ellen Wiebe was the woman in charge of the first Canadian trial of RU486.

Really, where are the feminists when you need them?

Facebooktwitterredditpinterestlinkedintumblrmailby feather

Filed Under: All Posts

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow Us

Facebooktwitterrssby feather

Notable Columns

  • A pro-woman budget wouldn't tell me how to live my life
  • Bad medicine
  • Birth control pills have side effects
  • Canada Summer Jobs debacle–Can Trudeau call abortion a right?
  • Celebrate these Jubilee jailbirds
  • China has laws against sex selection. But not Canada. Why?
  • Family love is not a contract
  • Freedom to discuss the “choice”
  • Gender quotas don't help business or women
  • Ghomeshi case a wake-up call
  • Hidden cost of choice
  • Life at the heart of the matter
  • Life issues and the media
  • Need for rational abortion debate
  • New face of the abortion debate
  • People vs. kidneys
  • PET-P press release
  • Pro-life work is making me sick
  • Prolife doesn't mean anti-woman
  • Settle down or "lean in"
  • Sex education is all about values
  • Thank you, Camille Paglia
  • The new face of feminism
  • Today’s law worth discussing
  • When debate is shut down in Canada’s highest places
  • Whither feminism?

Categories

  • All Posts
  • Assisted Suicide/Euthanasia
  • Charitable
  • Ethics
  • Featured Media
  • Featured Posts
  • Feminism
  • Free Expression
  • International
  • Motherhood
  • Other
  • Political
  • Pregnancy Care Centres
  • Reproductive Technologies

All Posts

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2025 · News Pro Theme on Genesis Framework · WordPress · Log in